sentence1 stringlengths 1.08k 96.5k | sentence2 stringlengths 51 966 | labels stringclasses 3
values | metadata stringlengths 123 2.56k |
|---|---|---|---|
Background
Transplantation of adventitial pericytes (APCs) promotes cardiac repair in murine models of myocardial infarction. The aim of present study was to confirm the benefit of APC therapy in a large animal model.
Methods and Results
We performed a blind, randomized, placebo‐controlled APC therapy trial in a s... | Intervention: Transplantation of adventitial pericytes (APCs)
Comparator: placebo
Outcome: ejection fraction | 0 | {"evidence_spans": [{"end": 793, "start": 699, "text": "ry. Transplantation of hAPCs reduced fibrosis but failed to improve the other efficacy end poi"}, {"end": 63497, "start": 63351, "text": "ge, y\r\nNot reported\r\n57\u00b16\r\n73\u00b13*\r\n\r\nHuman cell donor sex (M/F)\r\nNot reported\r\n8/1\r\n6/1\r\nCell dose ... |
Background
Transplantation of adventitial pericytes (APCs) promotes cardiac repair in murine models of myocardial infarction. The aim of present study was to confirm the benefit of APC therapy in a large animal model.
Methods and Results
We performed a blind, randomized, placebo‐controlled APC therapy trial in a s... | Intervention: Transplantation of adventitial pericytes (APCs)
Comparator: placebo
Outcome: cardiac magnetic resonance imaging indices of contractility | 0 | {"evidence_spans": [{"end": 1332, "start": 1175, "text": "Cs. Transplantation of allogeneic sAPCs benefited capillary density and fibrosis but did not improve cardiac magnetic resonance imaging indices of contractil"}], "id": "12390", "pmcid": "5850145", "prompt_id": "12390", "split_group_id": "5850145", "votes": {"0":... |
Background
Apremilast, a specific inhibitor of phosphodiesterase 4, modulates pro-inflammatory and anti-inflammatory cytokine production.
Objectives
Apremilast’s effect on patient-reported outcomes (PROs) in patients with moderate to severe psoriasis was evaluated in a phase IIb randomized, controlled trial (NCT00... | Intervention: apremilast 20 mg or 30 mg
Comparator: placebo
Outcome: mean the Dermatology Life Quality Index (DLQI) scores at week 16 | -1 | {"evidence_spans": [{"end": 1128, "start": 958, "text": " in HRQOL. At 16 weeks, greater improvements from baseline in DLQI scores were reported with apremilast 20 (\u22125.9) and 30 mg BID (\u22124.4) compared with placebo (1.9; P\u22640.005"}, {"end": 11587, "start": 11425, "text": "s Area and Severity Index; PsA, ps... |
Background
Apremilast, a specific inhibitor of phosphodiesterase 4, modulates pro-inflammatory and anti-inflammatory cytokine production.
Objectives
Apremilast’s effect on patient-reported outcomes (PROs) in patients with moderate to severe psoriasis was evaluated in a phase IIb randomized, controlled trial (NCT00... | Intervention: apremilast 20 mg or 30 mg
Comparator: placebo
Outcome: pruritus VAS scores | -1 | {"evidence_spans": [{"end": 1419, "start": 1264, "text": " P<0.04). Greater improvements from baseline in pruritus VAS scores were reported with apremilast 20 (\u221235.5%) and 30 mg BID (\u221243.7%) versus placebo (\u22126.1%;"}, {"end": 12758, "start": 12553, "text": "6.8*\r\n*P\u22640.005 vs placebo.\r\nValues are ... |
Background
Apremilast, a specific inhibitor of phosphodiesterase 4, modulates pro-inflammatory and anti-inflammatory cytokine production.
Objectives
Apremilast’s effect on patient-reported outcomes (PROs) in patients with moderate to severe psoriasis was evaluated in a phase IIb randomized, controlled trial (NCT00... | Intervention: apremilast 20 mg or 30 mg
Comparator: placebo
Outcome: ≥minimum clinically important differences (MCID) | 1 | {"evidence_spans": [{"end": 1263, "start": 1134, "text": "oth), and a greater proportion of patients reported improvements \u2265MCID (20 mg BID, 49.4%, 30 mg BID, 44.3%) versus placebo (25.0%"}], "id": "12393", "pmcid": "3661377", "prompt_id": "12393", "split_group_id": "3661377", "votes": {"1": 2}} |
Background
Apremilast, a specific inhibitor of phosphodiesterase 4, modulates pro-inflammatory and anti-inflammatory cytokine production.
Objectives
Apremilast’s effect on patient-reported outcomes (PROs) in patients with moderate to severe psoriasis was evaluated in a phase IIb randomized, controlled trial (NCT00... | Intervention: apremilast 10 or 20 mg or 30 mg
Comparator: placebo
Outcome: mental component summary (MCS) scores | 1 | {"evidence_spans": [{"end": 13391, "start": 13162, "text": "\r\nSF-36 MCS and PCS scores\r\nAt baseline, mean SF-36 MCS scores across treatment groups were 0.5 SDs lower than US normative scores of 50 (range: 45.7\u201347.0), whereas SF-36 PCS scores approximated 50 (range 48.6\u201349.3). After 16 wee"}, {"end": 13320... |
Background
Apremilast, a specific inhibitor of phosphodiesterase 4, modulates pro-inflammatory and anti-inflammatory cytokine production.
Objectives
Apremilast’s effect on patient-reported outcomes (PROs) in patients with moderate to severe psoriasis was evaluated in a phase IIb randomized, controlled trial (NCT00... | Intervention: apremilast 10 or 20 mg or 30 mg
Comparator: placebo
Outcome: physical component summary (PCS) scores | 0 | {"evidence_spans": [{"end": 13590, "start": 13394, "text": "of treatment, mean changes from baseline in MCS scores were significantly greater with apremilast 10, 20, or 30 mg BID than placebo (Figure\u20091), exceeding MCID, and approaching US normative values "}], "id": "12395", "pmcid": "3661377", "prompt_id": "12395... |
Objective
Almonds reduce cardiovascular disease risk via cholesterol reduction, anti-inflammation, glucoregulation, and antioxidation. The objective of this randomized, controlled, cross-over trial was to determine whether the addition of 85 g almonds daily to a National Cholesterol Education Program (NCEP) Step 1 die... | Intervention: CON diet with almonds (85 g/day) (ALM)
Comparator: CON diet
Outcome: value of plasma α-tocopherol | 1 | {"evidence_spans": [{"end": 18332, "start": 18210, "text": "ON diet did not have a significant impact on either nutrient (Table\u00a02). Compared to the CON diet, the ALM diet increased t"}, {"end": 18389, "start": 18210, "text": "ON diet did not have a significant impact on either nutrient (Table\u00a02). Compared to ... |
Objective
Almonds reduce cardiovascular disease risk via cholesterol reduction, anti-inflammation, glucoregulation, and antioxidation. The objective of this randomized, controlled, cross-over trial was to determine whether the addition of 85 g almonds daily to a National Cholesterol Education Program (NCEP) Step 1 die... | Intervention: CON diet with almonds (85 g/day) (ALM)
Comparator: CON diet
Outcome: value of plasma γ-tocopherol | -1 | {"evidence_spans": [{"end": 18388, "start": 18209, "text": "CON diet did not have a significant impact on either nutrient (Table\u00a02). Compared to the CON diet, the ALM diet increased the post-intervention value of plasma \u03b1-tocopherol by 10."}], "id": "12397", "pmcid": "4469426", "prompt_id": "12397", "split_gr... |
Objective
Almonds reduce cardiovascular disease risk via cholesterol reduction, anti-inflammation, glucoregulation, and antioxidation. The objective of this randomized, controlled, cross-over trial was to determine whether the addition of 85 g almonds daily to a National Cholesterol Education Program (NCEP) Step 1 die... | Intervention: CON diet with almonds (85 g/day) (ALM)
Comparator: CON diet
Outcome: Plasma Lipid Profile (Total cholesterol, HDL-C, LDL-C,Total triglycerides, Small dense LDL-C, Apo-B100, Apo-AI) | 0 | {"evidence_spans": [{"end": 25507, "start": 25150, "text": " measured in the finger, PWV pulse wave velocity, SBP systolic blood pressure\r\nbNitroglycerin-mediated dilation (NMD) of the brachial artery, n\u2009=\u200922 participants because some subjects did not participate in this portion of the study if their SBP wa... |
Objective
Almonds reduce cardiovascular disease risk via cholesterol reduction, anti-inflammation, glucoregulation, and antioxidation. The objective of this randomized, controlled, cross-over trial was to determine whether the addition of 85 g almonds daily to a National Cholesterol Education Program (NCEP) Step 1 die... | Intervention: CON diet with almonds (85 g/day) (ALM)
Comparator: CON diet
Outcome: Plasma Inflammatory cytokines (C-reactive Protein, TNFα, IL-6) | 0 | {"evidence_spans": [{"end": 25612, "start": 25508, "text": "se reaction to nitroglycerin\r\n\r\n\r\nBiochemical biomarkers\r\nThe lipid profiles of the subjects, including "}, {"end": 26813, "start": 26611, "text": "\r\n148.6\u2009\u00b1\u200938.3\r\n\u2003HDL-C, mg/dL\r\n41.0\u2009\u00b1\u200911.2\r\n41.7\u2009\u00b1\... |
Objective
Almonds reduce cardiovascular disease risk via cholesterol reduction, anti-inflammation, glucoregulation, and antioxidation. The objective of this randomized, controlled, cross-over trial was to determine whether the addition of 85 g almonds daily to a National Cholesterol Education Program (NCEP) Step 1 die... | Intervention: CON diet with almonds (85 g/day) (ALM)
Comparator: CON diet
Outcome: Endothelial function (Plasma E-selectin, Plasma VCAM-1, Plasma nitric oxide, Urinary nitric oxide) | 0 | {"evidence_spans": [{"end": 25741, "start": 25613, "text": "C, HDL-C, LDL-C, TG, and small density LDL-C, was unchanged during the study (Table\u00a04). VLDL-C values were calculated from TG co"}, {"end": 26810, "start": 26611, "text": "\r\n148.6\u2009\u00b1\u200938.3\r\n\u2003HDL-C, mg/dL\r\n41.0\u2009\u00b1\u200911.2... |
Background
In patients with chronic hepatitis C (CHC), obesity is involved in the pathogenesis of insulin resistance, fatty liver disease and progression of fibrosis. The objective of this study was to compare a normoglucidic low-calorie diet (NGLCD) with a low-fat diet (LFD) among participants with CHC. Aimed to meas... | Intervention: normoglucidic low-calorie diet (NGLCD)
Comparator: low-fat diet (LFD)
Outcome: weight loss At 6 months | -1 | {"evidence_spans": [{"end": 21781, "start": 21627, "text": "in caloric consumption (Table\u00a02), without differences between groups (p\u2009=\u20090.839 at 6 months, and p\u2009=\u20090.96 at 12 months); at 12 months, fat consumption in "}], "id": "12402", "pmcid": "3751456", "prompt_id": "12402", "split_group_id": "... |
Background
In patients with chronic hepatitis C (CHC), obesity is involved in the pathogenesis of insulin resistance, fatty liver disease and progression of fibrosis. The objective of this study was to compare a normoglucidic low-calorie diet (NGLCD) with a low-fat diet (LFD) among participants with CHC. Aimed to meas... | Intervention: normoglucidic low-calorie diet (NGLCD)
Comparator: low-fat diet (LFD)
Outcome: weight loss at 1 year | 0 | {"evidence_spans": [{"end": 1497, "start": 1393, "text": "group. At 1-year, however, weight loss was similar in both groups (\u22123.9\u2009\u00b1\u20093.3 kg vs. \u22123.1\u2009\u00b1\u20092.6 kg; p\u2009=\u2009"}, {"end": 21912, "start": 21782, "text": "FD patients was significantly lower (43.3\u2009\u00b1\u20097.04 ... |
Background
In patients with chronic hepatitis C (CHC), obesity is involved in the pathogenesis of insulin resistance, fatty liver disease and progression of fibrosis. The objective of this study was to compare a normoglucidic low-calorie diet (NGLCD) with a low-fat diet (LFD) among participants with CHC. Aimed to meas... | Intervention: normoglucidic low-calorie diet (NGLCD)
Comparator: low-fat diet (LFD)
Outcome: severity of steatosis | 0 | {"evidence_spans": [{"end": 34324, "start": 34172, "text": "0.7\r\n0.4\r\n0.3\r\n.\r\n0.887\r\nLFD low fat diet, PA physical activity, BMI body mass index, AST aspartate aminotransferase, ALT alanine aminotransferase, Bi b"}, {"end": 34500, "start": 34172, "text": "0.7\r\n0.4\r\n0.3\r\n.\r\n0.887\r\nLFD low fat diet, P... |
Background
In patients with chronic hepatitis C (CHC), obesity is involved in the pathogenesis of insulin resistance, fatty liver disease and progression of fibrosis. The objective of this study was to compare a normoglucidic low-calorie diet (NGLCD) with a low-fat diet (LFD) among participants with CHC. Aimed to meas... | Intervention: normoglucidic low-calorie diet (NGLCD)
Comparator: low-fat diet (LFD)
Outcome: renal function (eGFR, creatinin, urea) | 0 | {"evidence_spans": [{"end": 35480, "start": 35368, "text": "s. 76.2%, moderate: 29.2% vs. 23.8%, severe: 12.5% vs. 0%.\r\nThis reduction in prevalence and severity of liver s"}, {"end": 35648, "start": 35368, "text": "s. 76.2%, moderate: 29.2% vs. 23.8%, severe: 12.5% vs. 0%.\r\nThis reduction in prevalence and severit... |
Background
Despite evidence on efficacious interventions, a great proportion of depressed adolescents do not receive evidence-based treatment and have no access to specialized mental health care. Remote collaborative depression care (RCDC) may help to reduce the gap between needs and specialized mental health services... | Intervention: Remote collaborative depression care (RCDC)
Comparator: enhanced usual care or EUC
Outcome: adherence to pharmacological treatment | 0 | {"evidence_spans": [{"end": 18610, "start": 18451, "text": " sample displayed a regular intake of the psychoactive medications prescribed (n=44). No significant differences were observed across groups at 12-week follow-"}], "id": "12406", "pmcid": "5812981", "prompt_id": "12406", "split_group_id": "5812981", "votes": {... |
Background
Despite evidence on efficacious interventions, a great proportion of depressed adolescents do not receive evidence-based treatment and have no access to specialized mental health care. Remote collaborative depression care (RCDC) may help to reduce the gap between needs and specialized mental health services... | Intervention: Remote collaborative depression care (RCDC)
Comparator: enhanced usual care or EUC
Outcome: Satisfaction with psychological care | 1 | {"evidence_spans": [{"end": 18939, "start": 18707, "text": "on outcomes reached 6 points on a scale from 1 to 7, with no differences across arms. Satisfaction with psychological care was the only aspect of treatment satisfaction that displayed a significant difference between the groups (Wil"}], "id": "12407", "pmcid":... |
Purpose
We evaluated the efficacy of alfuzosin for the treatment of ureteral calculi less than 10 mm in diameter after extracorporeal shock wave lithotripsy (ESWL).
Materials and Methods
A randomized, single-blind clinical trial was performed prospectively by one physician between June 2010 and August 2011. A tota... | Intervention: Alfuzosin 10 mg (once daily) and loxoprofen sodium 68.1 mg (as needed) were prescribed to group 1
Comparator: loxoprofen sodium 68.1 mg (as needed) only was prescribed to group 2
Outcome: the number of extracorporeal shock wave lithotripsy (ESWL) | 0 | {"evidence_spans": [{"end": 974, "start": 877, "text": "0.96). The number of ESWL sessions was 1.34\u00b10.65 and 1.41\u00b10.85 in groups 1 and 2, respectively (p"}], "id": "12408", "pmcid": "3580299", "prompt_id": "12408", "split_group_id": "3580299", "votes": {"0": 2}} |
Purpose
We evaluated the efficacy of alfuzosin for the treatment of ureteral calculi less than 10 mm in diameter after extracorporeal shock wave lithotripsy (ESWL).
Materials and Methods
A randomized, single-blind clinical trial was performed prospectively by one physician between June 2010 and August 2011. A tota... | Intervention: Alfuzosin 10 mg (once daily) and loxoprofen sodium 68.1 mg (as needed) were prescribed to group 1
Comparator: loxoprofen sodium 68.1 mg (as needed) only was prescribed to group 2
Outcome: ultimately passed stones | 0 | {"evidence_spans": [{"end": 875, "start": 755, "text": "sults\r\nThirty-nine of 41 (95.1%) patients in group 1 and 40 of 43 (93.0%) patients in group 2 ultimately passed stones ("}, {"end": 876, "start": 755, "text": "sults\r\nThirty-nine of 41 (95.1%) patients in group 1 and 40 of 43 (93.0%) patients in group 2 ultima... |
Purpose
We evaluated the efficacy of alfuzosin for the treatment of ureteral calculi less than 10 mm in diameter after extracorporeal shock wave lithotripsy (ESWL).
Materials and Methods
A randomized, single-blind clinical trial was performed prospectively by one physician between June 2010 and August 2011. A tota... | Intervention: Alfuzosin 10 mg (once daily) and loxoprofen sodium 68.1 mg (as needed) were prescribed to group 1
Comparator: loxoprofen sodium 68.1 mg (as needed) only was prescribed to group 2
Outcome: The patients who required analgesics after ESWL | 0 | {"evidence_spans": [{"end": 1084, "start": 975, "text": "0.33). The patients who required analgesics after ESWL were 8 (19.5%) in group 1 and 13 (30.2%) in group 2 (p"}], "id": "12410", "pmcid": "3580299", "prompt_id": "12410", "split_group_id": "3580299", "votes": {"0": 2}} |
Purpose
We evaluated the efficacy of alfuzosin for the treatment of ureteral calculi less than 10 mm in diameter after extracorporeal shock wave lithotripsy (ESWL).
Materials and Methods
A randomized, single-blind clinical trial was performed prospectively by one physician between June 2010 and August 2011. A tota... | Intervention: Alfuzosin 10 mg (once daily) and loxoprofen sodium 68.1 mg (as needed) were prescribed to group 1
Comparator: loxoprofen sodium 68.1 mg (as needed) only was prescribed to group 2
Outcome: severity scores | 0 | {"evidence_spans": [{"end": 1198, "start": 1084, "text": "=0.31). Visual analogue scale pain severity scores were 5.33\u00b11.22 and 6.43\u00b11.36 in groups 1 and 2, respectively (p"}, {"end": 1199, "start": 1085, "text": "0.31). Visual analogue scale pain severity scores were 5.33\u00b11.22 and 6.43\u00b11.36 in grou... |
Purpose
We evaluated the efficacy of alfuzosin for the treatment of ureteral calculi less than 10 mm in diameter after extracorporeal shock wave lithotripsy (ESWL).
Materials and Methods
A randomized, single-blind clinical trial was performed prospectively by one physician between June 2010 and August 2011. A tota... | Intervention: Alfuzosin 10 mg (once daily) and loxoprofen sodium 68.1 mg (as needed) were prescribed to group 1
Comparator: loxoprofen sodium 68.1 mg (as needed) only was prescribed to group 2
Outcome: The time to stone expulsion | -1 | {"evidence_spans": [{"end": 1304, "start": 1199, "text": "0.056). The time to stone expulsion in groups 1 and 2 was 9.5\u00b14.8 days and 14.7\u00b19.8 days, respectively (p"}, {"end": 1305, "start": 1200, "text": ".056). The time to stone expulsion in groups 1 and 2 was 9.5\u00b14.8 days and 14.7\u00b19.8 days, respec... |
Background
Insecticide-treated bed nets (ITNs) are now the main tool for malaria prevention in endemic areas. Synthetic pyrethroids are the only group of insecticides recommended by the World Health Organization for the use on ITNs. There are only few studies which have specifically investigated potential adverse effe... | Intervention: ITNs from birth (group A)
Comparator: from age 6 months (group B)
Outcome: frequency and duration of side effects | 0 | {"evidence_spans": [{"end": 1291, "start": 1179, "text": "ow up. There were no significant differences in the frequency and duration of side effects between the two study"}, {"end": 9921, "start": 9777, "text": "mation, stomach ache and constipation. There were no significant differences in the frequency and duration o... |
Background
Insecticide-treated bed nets (ITNs) are now the main tool for malaria prevention in endemic areas. Synthetic pyrethroids are the only group of insecticides recommended by the World Health Organization for the use on ITNs. There are only few studies which have specifically investigated potential adverse effe... | Intervention: ITNs from birth (group A)
Comparator: from age 6&nbsp;months (group B)
Outcome: the frequency of headache | 1 | {"evidence_spans": [{"end": 1406, "start": 1293, "text": "roups, except that the frequency of headache was significantly higher in group A compared to group B mothers (p\u00a0="}, {"end": 1406, "start": 1305, "text": "t that the frequency of headache was significantly higher in group A compared to group B mothers (p\u0... |
Background and objective
An adjusted indirect comparison was conducted to assess efficacy outcomes, particularly overall survival (OS), of osimertinib versus platinum-based doublet chemotherapy in patients with epidermal growth factor receptor-mutated (EGFRm) T790M mutation-positive non-small-cell lung cancer (NSCLC) ... | Intervention: osimertinib
Comparator: platinum-based doublet chemotherapy
Outcome: progression-free survival (PFS) | 1 | {"evidence_spans": [{"end": 1505, "start": 1182, "text": "sults\r\nAfter adjustment for baseline differences between the two groups, osimertinib demonstrated a statistically significant improvement in progression-free survival (PFS) versus platinum-based doublet chemotherapy (hazard ratio [HR]\u00a0=\u00a00.278, 95% co... |
Background and objective
An adjusted indirect comparison was conducted to assess efficacy outcomes, particularly overall survival (OS), of osimertinib versus platinum-based doublet chemotherapy in patients with epidermal growth factor receptor-mutated (EGFRm) T790M mutation-positive non-small-cell lung cancer (NSCLC) ... | Intervention: osimertinib
Comparator: platinum-based doublet chemotherapy
Outcome: objective response rate (ORR) and disease control rate | 1 | {"evidence_spans": [{"end": 1741, "start": 1506, "text": "nths). Improvements were also observed for objective response rate (ORR) and disease control rate (DCR) (ORR: 64.3 vs. 33.3%; odds ratio [OR]\u00a0=\u00a05.31, 95% CI 2.47\u201311.40, p\u00a0<\u00a00.001; DCR: 92.1 vs. 75.0%; OR\u00a0=\u00a04.72, 95% CI 1.92\u20... |
Introduction
Meropenem bactericidal activity depends on the time when the free drug concentrations remain above the minimum inhibitory concentration of pathogens. The goal of this study was to compare clinical and bacteriological efficacy of continuous meropenem infusion versus bolus administration in critically ill p... | Intervention: Infusion group
Comparator: Bolus group
Outcome: Microbiological success rate | 1 | {"evidence_spans": [{"end": 1408, "start": 1287, "text": ".180). Microbiological success rate was higher in the Infusion group as opposed to the Bolus group (90.6% vs. 78.4%; P = "}], "id": "12418", "pmcid": "3580671", "prompt_id": "12418", "split_group_id": "3580671", "votes": {"1": 2}} |
Introduction
Meropenem bactericidal activity depends on the time when the free drug concentrations remain above the minimum inhibitory concentration of pathogens. The goal of this study was to compare clinical and bacteriological efficacy of continuous meropenem infusion versus bolus administration in critically ill p... | Intervention: Infusion group
Comparator: Bolus group
Outcome: Meropenem-related ICU stay | -1 | {"evidence_spans": [{"end": 1738, "start": 1597, "text": ".040). Meropenem-related ICU stay was shorter in the Infusion group compared to the Bolus group (10 (7 to 14) days vs. 12 (7 to 19) days; P ="}], "id": "12419", "pmcid": "3580671", "prompt_id": "12419", "split_group_id": "3580671", "votes": {"-1": 2}} |
Introduction
Meropenem bactericidal activity depends on the time when the free drug concentrations remain above the minimum inhibitory concentration of pathogens. The goal of this study was to compare clinical and bacteriological efficacy of continuous meropenem infusion versus bolus administration in critically ill p... | Intervention: Infusion group
Comparator: Bolus group
Outcome: duration of meropenem therapy | -1 | {"evidence_spans": [{"end": 1837, "start": 1750, "text": "ell as shorter duration of meropenem therapy (7 (6 to 8) days vs. 8 (7 to 10) days; P ="}], "id": "12420", "pmcid": "3580671", "prompt_id": "12420", "split_group_id": "3580671", "votes": {"-1": 2}} |
Introduction
Meropenem bactericidal activity depends on the time when the free drug concentrations remain above the minimum inhibitory concentration of pathogens. The goal of this study was to compare clinical and bacteriological efficacy of continuous meropenem infusion versus bolus administration in critically ill p... | Intervention: Infusion group
Comparator: Bolus group
Outcome: total dose of meropenem | -1 | {"evidence_spans": [{"end": 1929, "start": 1596, "text": "0.040). Meropenem-related ICU stay was shorter in the Infusion group compared to the Bolus group (10 (7 to 14) days vs. 12 (7 to 19) days; P = 0.044) as well as shorter duration of meropenem therapy (7 (6 to 8) days vs. 8 (7 to 10) days; P = 0.035) and lower tot... |
Introduction
Meropenem bactericidal activity depends on the time when the free drug concentrations remain above the minimum inhibitory concentration of pathogens. The goal of this study was to compare clinical and bacteriological efficacy of continuous meropenem infusion versus bolus administration in critically ill p... | Intervention: Infusion group
Comparator: Bolus group
Outcome: adverse events | 0 | {"evidence_spans": [{"end": 2021, "start": 1930, "text": ".0001). No severe adverse events related to meropenem administration in either group were o"}, {"end": 32089, "start": 31955, "text": "f antibiotics given before the start of meropenem (OR = 0.581; 95% CI = 0.383 to 0.881; P = 0.011). The performance of the fina... |
Purpose:
To investigate visual performance during reading under different illumination sources.
Methods:
This experimental quantitative study included 40 (20 females and 20 males) emmetropic participants with no history of ocular pathology. The participants were randomly assigned to read a near visual task under f... | Intervention: compact fluorescent light (CFL), tungsten light (TUNG)
Comparator: fluorescent tube light (FLUO), and light emitting diode (LED)
Outcome: reading rates of males and females | 0 | {"evidence_spans": [{"end": 800, "start": 658, "text": " years. There was no statistically significant difference between the reading rates of males and females under the different illuminations (P "}, {"end": 801, "start": 659, "text": "years. There was no statistically significant difference between the reading rates... |
Background.
Improved influenza vaccine strategies for infants and preschool children are a high priority.
Methods.
The immunological response and safety of a thimerosal-free trivalent inactivated influenza vaccine at 2 different doses (0.50 mL vs 0.25 mL) was evaluated in children aged 6–35 months. The study was r... | Intervention: thimerosal-free trivalent inactivated influenza vaccine at 2 different doses 0.50 mL
Comparator: thimerosal-free trivalent inactivated influenza vaccine at 2 different doses 0.25 mL
Outcome: improvement in immune responses, reactogenicity and safety | 0 | {"evidence_spans": [{"end": 959, "start": 772, "text": "strata. A modest but not statistically significant improvement in immune responses was observed with the higher dose and reactogenicity, and safety of the 2 doses was not significantly di"}, {"end": 960, "start": 773, "text": "trata. A modest but not statistically... |
Background
Neonatal respiratory distress syndrome, as a consequence of preterm birth, is a major cause of early mortality and morbidity. The withdrawal of progesterone, either actual or functional, is thought to be an antecedent to the onset of labour. There remains limited information on clinically relevant health ou... | Intervention: vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone)
Comparator: placebo
Outcome: The incidence of respiratory distress syndrome | 0 | {"evidence_spans": [{"end": 2338, "start": 2092, "text": "roup). The incidence of respiratory distress syndrome was similar in both study groups\u201410.5% (42/402) in the progesterone group and 10.6% (41/388) in the placebo group (adjusted relative risk [RR] 0.98, 95% confidence interval [CI] 0.64\u20131.49, p ="}], "... |
Background
Neonatal respiratory distress syndrome, as a consequence of preterm birth, is a major cause of early mortality and morbidity. The withdrawal of progesterone, either actual or functional, is thought to be an antecedent to the onset of labour. There remains limited information on clinically relevant health ou... | Intervention: vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone)
Comparator: placebo
Outcome: severity of any neonatal respiratory disease | 0 | {"evidence_spans": [{"end": 2457, "start": 2092, "text": "roup). The incidence of respiratory distress syndrome was similar in both study groups\u201410.5% (42/402) in the progesterone group and 10.6% (41/388) in the placebo group (adjusted relative risk [RR] 0.98, 95% confidence interval [CI] 0.64\u20131.49, p = 0.912... |
Background
Neonatal respiratory distress syndrome, as a consequence of preterm birth, is a major cause of early mortality and morbidity. The withdrawal of progesterone, either actual or functional, is thought to be an antecedent to the onset of labour. There remains limited information on clinically relevant health ou... | Intervention: vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone)
Comparator: placebo
Outcome: other respiratory morbidities and adverse infant outcomes, including serious infant composite outcome | 0 | {"evidence_spans": [{"end": 2609, "start": 2458, "text": ".905). No differences were seen between study groups for other respiratory morbidities and adverse infant outcomes, including serious infant composite "}, {"end": 2742, "start": 2458, "text": ".905). No differences were seen between study groups for other respir... |
Background
Neonatal respiratory distress syndrome, as a consequence of preterm birth, is a major cause of early mortality and morbidity. The withdrawal of progesterone, either actual or functional, is thought to be an antecedent to the onset of labour. There remains limited information on clinically relevant health ou... | Intervention: vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone)
Comparator: placebo
Outcome: side effects | 0 | {"evidence_spans": [{"end": 3332, "start": 3129, "text": "tment. In 9.9% (39/394) of the women in the progesterone group and 7.3% (28/382) of the women in the placebo group, treatment was stopped because of side effects (adjusted RR 1.35, 95% CI 0.85\u20132.15, p = "}, {"end": 36485, "start": 36099, "text": "eterm birt... |
Background
The present study was designed in quasi-experiment to assess adoption of the essential clauses of particular clinical laboratory quality management requirements based on international organization for standardization (ISO 15189) in hospital laboratories and to evaluate the cost effectiveness of compliance t... | Intervention: international organization for standardization (ISO 15189) courses
Comparator: control group
Outcome: annual average total costs per-test | -1 | {"evidence_spans": [{"end": 11125, "start": 10913, "text": " with insignificant effect (P= 0.39) (Table 4), whereas the post-intervention results showed that the annual average total costs per-test for study and control groups was 1.57 \u00b1 0.23 and 2.08 \u00b1 0.38 SDG, respecti"}], "id": "12435", "pmcid": "3744251"... |
Background
The present study was designed in quasi-experiment to assess adoption of the essential clauses of particular clinical laboratory quality management requirements based on international organization for standardization (ISO 15189) in hospital laboratories and to evaluate the cost effectiveness of compliance t... | Intervention: international organization for standardization (ISO 15189) courses
Comparator: control group
Outcome: cost effectiveness | -1 | {"evidence_spans": [{"end": 11538, "start": 11323, "text": "0.91 and cost-effectiveness ratio 0.88 (Table 5) while in post-intervention results the cost effectiveness of the study group (1.98) was substantially lower than that of control group (3.84) with efficiency ratio (0"}], "id": "12436", "pmcid": "3744251", "prom... |
Background
The present study was designed in quasi-experiment to assess adoption of the essential clauses of particular clinical laboratory quality management requirements based on international organization for standardization (ISO 15189) in hospital laboratories and to evaluate the cost effectiveness of compliance t... | Intervention: international organization for standardization (ISO 15189) courses
Comparator: control group
Outcome: The compliance to ISO 15189 | 1 | {"evidence_spans": [{"end": 10659, "start": 10177, "text": "hereas the creatinine was kinetic technique.\r\nThe compliance of study group and control group to ISO15189 was 49% for study group vs. 47% for control group with P value 0.48 in pre-intervention phase and 79 % for study group vs. 54% for control group with P ... |
BACKGROUND:
Studies have shown that administration of anthelmintic drugs in pregnancy can reduce the incidence of maternal anaemia; however, data on other maternal and perinatal outcomes are limited.
AIM:
This study was therefore conducted to evaluate the direct impact of mass deworming on delivery and perinatal o... | Intervention: oral mebendazole (500 mg)
Comparator: placebo
Outcome: incidences of postpartum haemorrhage, puerperal pyrexia, low birth weight, asphyxia and perinatal death | 0 | {"evidence_spans": [{"end": 1181, "start": 962, "text": "= 0.047). There were no statistically significant differences in incidences of postpartum haemorrhage (p = 0.119), Puerperal, pyrexia (p = 0.943), low birth weight (p = 0.556) asphyxia (p = 0.706) and perinatal death (p"}], "id": "12439", "pmcid": "5985893", "pro... |
OBJECTIVE:
To investigate the value of high-flow nasal cannula oxygen therapy after extubation in patients with acute respiratory failure.
METHODS:
A single-center, prospective, randomized, controlled pilot trial was conducted between January 2013 and December 2014. Sixty enrolled patients were randomized immediat... | Intervention: high-flow nasal cannula
Comparator: air entrainment mask
Outcome: the PaO2 and SpO2 at 24h after extubation | 1 | {"evidence_spans": [{"end": 11218, "start": 11001, "text": "group was 36.8\u00b12.8 L/min. In addition, the HFNC significantly improved the PaO2 and SpO2 at 24h after extubation compared to the air entrainment mask (83.2\u00b110.5 mmHg vs. 74.5\u00b113.1 mmHg, p=0.016; 98.0\u00b11.3% vs. 96.9\u00b11.4"}, {"end": 11219,... |
OBJECTIVE:
To investigate the value of high-flow nasal cannula oxygen therapy after extubation in patients with acute respiratory failure.
METHODS:
A single-center, prospective, randomized, controlled pilot trial was conducted between January 2013 and December 2014. Sixty enrolled patients were randomized immediat... | Intervention: high-flow nasal cannula
Comparator: air entrainment mask
Outcome: The PaCO2 values | 0 | {"evidence_spans": [{"end": 11281, "start": 11219, "text": ", p=0.011, respectively). The PaCO2 values were similar betwee"}, {"end": 11292, "start": 11220, "text": " p=0.011, respectively). The PaCO2 values were similar between the two g"}], "id": "12442", "pmcid": "5629746", "prompt_id": "12442", "split_group_id": "5... |
OBJECTIVE:
To investigate the value of high-flow nasal cannula oxygen therapy after extubation in patients with acute respiratory failure.
METHODS:
A single-center, prospective, randomized, controlled pilot trial was conducted between January 2013 and December 2014. Sixty enrolled patients were randomized immediat... | Intervention: high-flow nasal cannula
Comparator: air entrainment mask
Outcome: The respiratory rate | -1 | {"evidence_spans": [{"end": 11449, "start": 11292, "text": "roups (p=0.591, Table 2). The respiratory rate was significantly lower for the HFNC group than for the air entrainment mask group (22\u00b13.6 breaths/min vs. 26\u00b1"}, {"end": 11450, "start": 11293, "text": "oups (p=0.591, Table 2). The respiratory rate was... |
OBJECTIVE:
To investigate the value of high-flow nasal cannula oxygen therapy after extubation in patients with acute respiratory failure.
METHODS:
A single-center, prospective, randomized, controlled pilot trial was conducted between January 2013 and December 2014. Sixty enrolled patients were randomized immediat... | Intervention: high-flow nasal cannula
Comparator: air entrainment mask
Outcome: heart rate and mean arterial pressure | 0 | {"evidence_spans": [{"end": 11566, "start": 11451, "text": "3 breaths/min, p=0.003). No significant differences in heart rate and mean arterial pressure were observed between "}], "id": "12444", "pmcid": "5629746", "prompt_id": "12444", "split_group_id": "5629746", "votes": {"0": 2}} |
OBJECTIVE:
To investigate the value of high-flow nasal cannula oxygen therapy after extubation in patients with acute respiratory failure.
METHODS:
A single-center, prospective, randomized, controlled pilot trial was conducted between January 2013 and December 2014. Sixty enrolled patients were randomized immediat... | Intervention: high-flow nasal cannula
Comparator: air entrainment mask
Outcome: Discomforts related to the interface and symptoms of airway dryness | -1 | {"evidence_spans": [{"end": 11781, "start": 11567, "text": "he two groups (Table 2).\r\nDiscomforts related to the interface and symptoms of airway dryness were significantly lower in the HFNC group than those in the air entrainment mask group [3(3-4.5) vs. 7(6-8); 3(2-3.5) v"}, {"end": 11793, "start": 11567, "text": "... |
Objectives
Extended-release (ER) carbidopa-levodopa (CD-LD) (IPX066/RYTARY/NUMIENT) produces improvements in “off” time, “on” time without troublesome dyskinesia, and Unified Parkinson Disease Rating Scale scores compared with immediate-release (IR) CD-LD or IR CD-LD plus entacapone (CLE). Post hoc analyses of 2 ER CD... | Intervention: Extended-release (ER) carbidopa-levodopa (CD-LD)
Comparator: immediate-release (IR) CD-LD or IR CD-LD plus entacapone (CLE)
Outcome: “off” time | -1 | {"evidence_spans": [{"end": 11181, "start": 10931, "text": "fects of Concomitant Dopaminergic Agonists\r\nThe decrease from baseline to end of double-blind treatment in \u201coff\u201d time was significantly greater in patients given ER CD-LD versus IR CD-LD (Fig. 1A) or ER CD-LD versus CLE (Fig. 1D) with or without co... |
Objectives
Extended-release (ER) carbidopa-levodopa (CD-LD) (IPX066/RYTARY/NUMIENT) produces improvements in “off” time, “on” time without troublesome dyskinesia, and Unified Parkinson Disease Rating Scale scores compared with immediate-release (IR) CD-LD or IR CD-LD plus entacapone (CLE). Post hoc analyses of 2 ER CD... | Intervention: Extended-release (ER) carbidopa-levodopa (CD-LD)
Comparator: immediate-release (IR) CD-LD or IR CD-LD plus entacapone (CLE)
Outcome: “on” time without troublesome dyskinesia | 1 | {"evidence_spans": [{"end": 11427, "start": 11182, "text": "mitant dopaminergic agonist administration. The improvement in \u201con\u201d time without troublesome dyskinesia was significantly greater with ER CD-LD versus IR CD-LD (Fig. 1B; ADVANCE-PD) and with ER CD-LD versus CLE (Fig. 1E; ASCEND-PD) in patients r"}, {... |
Objectives
Extended-release (ER) carbidopa-levodopa (CD-LD) (IPX066/RYTARY/NUMIENT) produces improvements in “off” time, “on” time without troublesome dyskinesia, and Unified Parkinson Disease Rating Scale scores compared with immediate-release (IR) CD-LD or IR CD-LD plus entacapone (CLE). Post hoc analyses of 2 ER CD... | Intervention: Extended-release (ER) carbidopa-levodopa (CD-LD)
Comparator: immediate-release (IR) CD-LD or IR CD-LD plus entacapone (CLE)
Outcome: The overall percentage of adverse events | 0 | {"evidence_spans": [{"end": 15608, "start": 15431, "text": "ubgroup During the Double-blind Treatment Period in ASCEND-PD\r\nThe overall percentage of AEs for those patients taking concomitant medications was similar for ER LD-CD and IR CD"}], "id": "12448", "pmcid": "5865491", "prompt_id": "12448", "split_group_id": "... |
OBJECTIVE:
Remote ischemic preconditioning (RIPC) is a phenomenon in which a short period of sub-lethal ischemia in one organ protects against subsequent bouts of ischemia in another organ. We hypothesized that RIPC in patients with intermittent claudication would increase muscle tissue resistance to ischemia, thereby... | Intervention: no RIPC prior to the first treadmill test and RIPC prior to the second treadmill test
Comparator: 'both treadmill tests were performed without RIPC' or 'RIPC prior to the first treadmill test and no RIPC prior to the second treadmill test'
Outcome: claudication distances (ICDs) in the second treadmill tes... | 1 | {"evidence_spans": [{"end": 1336, "start": 1215, "text": "ULTS:\r\nGroup A showed a significant increase in the initial claudication distance in the second test compared to the firs"}, {"end": 7261, "start": 7172, "text": "fferences were found in Group B. Furthermore, the ICD was greater in Group A patients whe"}], "id... |
OBJECTIVE:
Remote ischemic preconditioning (RIPC) is a phenomenon in which a short period of sub-lethal ischemia in one organ protects against subsequent bouts of ischemia in another organ. We hypothesized that RIPC in patients with intermittent claudication would increase muscle tissue resistance to ischemia, thereby... | Intervention: no RIPC prior to the first treadmill test and RIPC prior to the second treadmill test
Comparator: 'both treadmill tests were performed without RIPC' or 'RIPC prior to the first treadmill test and no RIPC prior to the second treadmill test'
Outcome: the total walking distance (TWD) | 0 | {"evidence_spans": [{"end": 7484, "start": 7262, "text": " compared with the other groups. Table\u00a02 also shows that the total walking distance (TWD) was lower in the first test than in the second test for Group A and Group B. However, there were no significant differences between "}, {"end": 7485, "start": 7263, "t... |
Background
E-learning and blended learning approaches gain more and more popularity in emergency medicine curricula. So far, little data is available on the impact of such approaches on procedural learning and skill acquisition and their comparison with traditional approaches.
Objective
This study investigated the... | Intervention: paper handouts with two Web-based VPs with embedded video clips
Comparator: paper handouts
Outcome: key-feature test results at t1 | 1 | {"evidence_spans": [{"end": 17564, "start": 17396, "text": "7 participants, there were 5 out of 30 (17%) PBLS-qualified participants (paramedics) in the control group and 4 out of 27 (15%) in the intervention group.\r\n\r\nClinical "}], "id": "12452", "pmcid": "4526972", "prompt_id": "12452", "split_group_id": "4526972... |
Background
E-learning and blended learning approaches gain more and more popularity in emergency medicine curricula. So far, little data is available on the impact of such approaches on procedural learning and skill acquisition and their comparison with traditional approaches.
Objective
This study investigated the... | Intervention: paper handouts with two Web-based VPs with embedded video clips
Comparator: paper handouts
Outcome: adherence to the algorithm | 1 | {"evidence_spans": [{"end": 1570, "start": 1376, "text": "up at t1. At t2, the intervention group showed significantly better adherence to the algorithm and temporal demands, and better procedural quality of PBLS in objective measures than did the cont"}, {"end": 17901, "start": 17686, "text": "en the control group and... |
Background
E-learning and blended learning approaches gain more and more popularity in emergency medicine curricula. So far, little data is available on the impact of such approaches on procedural learning and skill acquisition and their comparison with traditional approaches.
Objective
This study investigated the... | Intervention: paper handouts with two Web-based VPs with embedded video clips
Comparator: paper handouts
Outcome: adherence to temporal specifications | 1 | {"evidence_spans": [{"end": 18196, "start": 18028, "text": "1).\r\n\r\nPerformance: Adherence to Algorithm\r\nRegarding adherence to the algorithm, the intervention group was already better than the control group at t1 (93.4%, SD 7.1 "}, {"end": 18262, "start": 18028, "text": "1).\r\n\r\nPerformance: Adherence to Algor... |
Background
E-learning and blended learning approaches gain more and more popularity in emergency medicine curricula. So far, little data is available on the impact of such approaches on procedural learning and skill acquisition and their comparison with traditional approaches.
Objective
This study investigated the... | Intervention: paper handouts with two Web-based VPs with embedded video clips
Comparator: paper handouts
Outcome: The performance quality score | 1 | {"evidence_spans": [{"end": 18748, "start": 18587, "text": "hich continued at t2 (82.4%, SD 17.8 vs 55.8%, SD 27.8; P<.001). Both groups showed significant improvements in temporal measures between t1 and t2 (P=.03 and P="}, {"end": 18948, "start": 18587, "text": "hich continued at t2 (82.4%, SD 17.8 vs 55.8%, SD 27.8;... |
Background
E-learning and blended learning approaches gain more and more popularity in emergency medicine curricula. So far, little data is available on the impact of such approaches on procedural learning and skill acquisition and their comparison with traditional approaches.
Objective
This study investigated the... | Intervention: paper handouts with two Web-based VPs with embedded video clips
Comparator: paper handouts
Outcome: The global ratings of competence | 1 | {"evidence_spans": [{"end": 19179, "start": 18949, "text": "of interrater agreement [35].\r\nThe performance quality score of the intervention group was significantly superior to that of the control group at t1 (68.2%, SD 15.0 vs 48.8%, SD 20.2; P<.001). After practical training, at t2, they"}, {"end": 19395, "start": ... |
Background
To compare the effects of low dose and high dose of statin treatment on endothelial function and carotid intima-media thickness (IMT) in patients with variant angina (VAP).
Methods
A total of 70 patients with VAP were divided into two groups; atorvastatin 10 mg treatment group (group I: n = 35, 54.2 ± 1... | Intervention: atorvastatin 10 mg
Comparator: atorvastatin 40 mg
Outcome: brachial Flow mediated vasodilation (FMD) after 6 months | 0 | {"evidence_spans": [{"end": 908, "start": 643, "text": "roups. After 6 months of statin therapy, FMD was significantly improved in both groups (7.7 \u00b1 2.5% to 8.9 \u00b1 2.2% in group I, p = 0.001, 7.9 \u00b1 2.7% to 9.5 \u00b1 2.8% in group II, p < 0.001), but the degree of FMD change and FMD at 6 month were not d... |
Background
To compare the effects of low dose and high dose of statin treatment on endothelial function and carotid intima-media thickness (IMT) in patients with variant angina (VAP).
Methods
A total of 70 patients with VAP were divided into two groups; atorvastatin 10 mg treatment group (group I: n = 35, 54.2 ± 1... | Intervention: atorvastatin 10 mg
Comparator: atorvastatin 40 mg
Outcome: Nitroglycerin-mediated dilation (NMD) of the brachial artery after 6 months | 0 | {"evidence_spans": [{"end": 10609, "start": 10442, "text": " NMD was not different between the groups. After 6 months of statin therapy, NMD was not changed in both groups (from 19.4 \u00b1 5.2% to 19.5 \u00b1 4.9% in group I, from 20.5 "}], "id": "12460", "pmcid": "3701780", "prompt_id": "12460", "split_group_id": "37... |
Background
To compare the effects of low dose and high dose of statin treatment on endothelial function and carotid intima-media thickness (IMT) in patients with variant angina (VAP).
Methods
A total of 70 patients with VAP were divided into two groups; atorvastatin 10 mg treatment group (group I: n = 35, 54.2 ± 1... | Intervention: atorvastatin 10 mg
Comparator: atorvastatin 40 mg
Outcome: carotid IMT and plaque after 6 months | 0 | {"evidence_spans": [{"end": 986, "start": 909, "text": "roups. Carotid IMT were not changed in both groups after 6 months of statin t"}, {"end": 11204, "start": 10807, "text": "id IMT was not different between the groups. The carotid IMT was not changed in both groups despite of 6 months of statin therapy (from 0.61 \u... |
Background
To compare the effects of low dose and high dose of statin treatment on endothelial function and carotid intima-media thickness (IMT) in patients with variant angina (VAP).
Methods
A total of 70 patients with VAP were divided into two groups; atorvastatin 10 mg treatment group (group I: n = 35, 54.2 ± 1... | Intervention: atorvastatin 40 mg
Comparator: atorvastatin 10 mg
Outcome: The decrease of total cholesterol | 1 | {"evidence_spans": [{"end": 9682, "start": 9594, "text": " changed significantly in both groups. The decrease of total cholesterol was significant"}], "id": "12462", "pmcid": "3701780", "prompt_id": "12462", "split_group_id": "3701780", "votes": {"1": 1}} |
Background
To compare the effects of low dose and high dose of statin treatment on endothelial function and carotid intima-media thickness (IMT) in patients with variant angina (VAP).
Methods
A total of 70 patients with VAP were divided into two groups; atorvastatin 10 mg treatment group (group I: n = 35, 54.2 ± 1... | Intervention: atorvastatin 40 mg
Comparator: atorvastatin 10 mg
Outcome: decrease of LDL-cholesterol | 0 | {"evidence_spans": [{"end": 9769, "start": 9594, "text": " changed significantly in both groups. The decrease of total cholesterol was significantly greater in group II than in group I, but the decrease of LDL-cholesterol was not sig"}, {"end": 9779, "start": 9683, "text": "y greater in group II than in group I, but th... |
Correction
After publication of this article
[1], we noted errors to the “body weight” row of Table three. The values for the controls of Δ1(wk 0 ~ wk 4) and Δ2(wk 0 ~ wk 8) should be negative (please see Table
1 below, a corrected version of Table three).
Table 1Body composition changes between baseline and wk 4, ... | Intervention: Calcium plus vitamin D3
Comparator: Control
Outcome: Body weight at week 4, 8, 12 | 0 | {"evidence_spans": [{"end": 584, "start": 485, "text": "\u200921)PBody weight (kg)\r\n\u22122.2\u2009\u00b1\u20091.4 b\r\n\u22121.7\u2009\u00b1\u20091.2\r\n0.16\r\n\u22123.3\u2009\u00b1\u20091.6\r\n\u22123.3\u2009\u00b1\u20091.4\r\n0.94\r\n\u22124.1\u2009\u00b1\u20091.8\r\n\u22123"}], "id": "12464", "pmcid": "3626633",... |
Correction
After publication of this article
[1], we noted errors to the “body weight” row of Table three. The values for the controls of Δ1(wk 0 ~ wk 4) and Δ2(wk 0 ~ wk 8) should be negative (please see Table
1 below, a corrected version of Table three).
Table 1Body composition changes between baseline and wk 4, ... | Intervention: Calcium plus vitamin D3
Comparator: Control
Outcome: Fat mass at week 4 | 0 | {"evidence_spans": [{"end": 625, "start": 585, "text": "5\u2009\u00b1\u20091.9\r\n0.25\r\nFat mass (kg)\r\n\u22121.7\u2009\u00b1\u20091.7"}], "id": "12465", "pmcid": "3626633", "prompt_id": "12465", "split_group_id": "3626633", "votes": {"0": 2}} |
Correction
After publication of this article
[1], we noted errors to the “body weight” row of Table three. The values for the controls of Δ1(wk 0 ~ wk 4) and Δ2(wk 0 ~ wk 8) should be negative (please see Table
1 below, a corrected version of Table three).
Table 1Body composition changes between baseline and wk 4, ... | Intervention: Calcium plus vitamin D3
Comparator: Control
Outcome: Fat mass at week 8 and 12 | -1 | {"evidence_spans": [], "id": "12466", "pmcid": "3626633", "prompt_id": "12466", "split_group_id": "3626633", "votes": {"-1": 1}} |
Correction
After publication of this article
[1], we noted errors to the “body weight” row of Table three. The values for the controls of Δ1(wk 0 ~ wk 4) and Δ2(wk 0 ~ wk 8) should be negative (please see Table
1 below, a corrected version of Table three).
Table 1Body composition changes between baseline and wk 4, ... | Intervention: Calcium plus vitamin D3
Comparator: Control
Outcome: Lean mass (kg) at week 4, 8 , 12 | 0 | {"evidence_spans": [{"end": 875, "start": 781, "text": ".01\r\n\u22122.6\u2009\u00b1\u20091.6\r\n\u22121.4\u2009\u00b1\u20091.5\r\n0.02\r\nLean mass (kg)\r\n\u22120.4\u2009\u00b1\u20091.0\r\n\u22120.5\u2009\u00b1\u20091.2\r\n0.77\r\n\u22120.8\u2009\u00b1\u20090.9\r\n\u2212"}], "id": "12467", "pmcid": "3626633", "prompt... |
Correction
After publication of this article
[1], we noted errors to the “body weight” row of Table three. The values for the controls of Δ1(wk 0 ~ wk 4) and Δ2(wk 0 ~ wk 8) should be negative (please see Table
1 below, a corrected version of Table three).
Table 1Body composition changes between baseline and wk 4, ... | Intervention: Calcium plus vitamin D3
Comparator: Control
Outcome: visceral fat area VFA (cm2) at week 8 , 12 | -1 | {"evidence_spans": [{"end": 1079, "start": 984, "text": "\u20090.3\r\n\u22120.2\u2009\u00b1\u20090.2\r\n<0.01\r\n\u22120.5\u2009\u00b1\u20090.2\r\n\u22120.3\u2009\u00b1\u20090.2\r\n0.01\r\nVFA (cm2) c\r\n\u22126.6\u2009\u00b1\u20097.6\r\n\u22122.9\u2009\u00b1\u20096.6\r\n0.1"}, {"end": 1051, "start": 1023, "text": ".3\... |
Background
Based on the sample of obese children with relative growth hormone deficiency (GHD), the objective of our study was to determine the effects of rhGH treatment on cardiovascular risk factors, including body mass index (BMI), lipid levels and glucose metabolism index.
Methods
A total of 43 obese children ... | Intervention: recombinant human growth hormone (rhGH)
Comparator: control
Outcome: BMI standard deviation scores (SDS) at the 6-month | -1 | {"evidence_spans": [{"end": 697, "start": 530, "text": "onths, subjects in the rhGH treatment group had significant reductions in BMI standard deviation scores (SDS) compared with controls (2.32\u2009\u00b1\u20090.85 vs. 2.80\u2009\u00b1\u20090.61; P\u00a0=\u2009"}, {"end": 19024, "start": 18840, "text": "and 2.73\u200... |
Background
Based on the sample of obese children with relative growth hormone deficiency (GHD), the objective of our study was to determine the effects of rhGH treatment on cardiovascular risk factors, including body mass index (BMI), lipid levels and glucose metabolism index.
Methods
A total of 43 obese children ... | Intervention: recombinant human growth hormone (rhGH)
Comparator: control
Outcome: Insulin-like growth factor 1(IGF-1) at the 3-month and 6-month | 1 | {"evidence_spans": [{"end": 19891, "start": 19524, "text": " of rhGH administration on IGF-1 level\r\nIGF-1 in the rhGH treatment group has no significant difference compared with those subjects in the control group at baseline (241.47\u2009\u00b1\u2009105.98 vs. 291.10\u2009\u00b1\u2009151.95\u00a0ng/mL, P\u00a0=\u200... |
Background
Based on the sample of obese children with relative growth hormone deficiency (GHD), the objective of our study was to determine the effects of rhGH treatment on cardiovascular risk factors, including body mass index (BMI), lipid levels and glucose metabolism index.
Methods
A total of 43 obese children ... | Intervention: recombinant human growth hormone (rhGH)
Comparator: control
Outcome: LDL-C at the 6-month | -1 | {"evidence_spans": [{"end": 983, "start": 870, "text": ".001). GH treatment reduced low density lipoprotein cholesterol (LDL-C) (2.20\u2009\u00b1\u20090.45 vs. 2.63\u2009\u00b1\u20090.76\u00a0mmol/L, P\u00a0=\u2009"}, {"end": 20280, "start": 20178, "text": "r baseline age, gender (P\u00a0<\u20090.001).\r\n\r\nEffects o... |
Background
Based on the sample of obese children with relative growth hormone deficiency (GHD), the objective of our study was to determine the effects of rhGH treatment on cardiovascular risk factors, including body mass index (BMI), lipid levels and glucose metabolism index.
Methods
A total of 43 obese children ... | Intervention: recombinant human growth hormone (rhGH)
Comparator: control
Outcome: HDL-C level | 1 | {"evidence_spans": [{"end": 1308, "start": 1166, "text": "), and increased high density lipoprotein cholesterol (HDL-C) (1.45\u2009\u00b1\u20090.40 vs. 1.19\u2009\u00b1\u20090.23\u00a0mmol/L, P\u00a0=\u20090.016) levels compared with the control"}, {"end": 20425, "start": 20281, "text": "\r\nP\u00a0=\u20090.005), where... |
Background
Based on the sample of obese children with relative growth hormone deficiency (GHD), the objective of our study was to determine the effects of rhGH treatment on cardiovascular risk factors, including body mass index (BMI), lipid levels and glucose metabolism index.
Methods
A total of 43 obese children ... | Intervention: recombinant human growth hormone (rhGH)
Comparator: control
Outcome: AST and ALT at the 6-month | -1 | {"evidence_spans": [{"end": 21209, "start": 20980, "text": "GH treatment and control groups did not differ significantly in AST and ALT at baseline. At the 3-month visit, there were no significant differences in change in AST and ALT between the rhGH treatment and the control group (Table"}, {"end": 26459, "start": 263... |
Background and Aims:
Head and neck movements alter the shape of the pharynx, resulting in changes in the oropharyngeal leaking pressures and ventilation with supragottic airway devices. We compared the effect of the different head-and-neck positions on the oropharyngeal leak pressures and ventilation with the I-Gel™ a... | Intervention: I-Gel™
Comparator: ProSeal™ laryngeal mask airway (PLMA)
Outcome: PIP during maximum flexion | 1 | {"evidence_spans": [{"end": 10531, "start": 10389, "text": "h ProSeal laryngeal mask airway and I-Gel\u2122\r\nSignificantly higher PIP was recorded with I-Gel\u2122 than PLMA during maximum flexion (17.7[4] vs. 14"}, {"end": 10520, "start": 10395, "text": "eal laryngeal mask airway and I-Gel\u2122\r\nSignificantly hig... |
Background and Aims:
Head and neck movements alter the shape of the pharynx, resulting in changes in the oropharyngeal leaking pressures and ventilation with supragottic airway devices. We compared the effect of the different head-and-neck positions on the oropharyngeal leak pressures and ventilation with the I-Gel™ a... | Intervention: I-Gel™
Comparator: ProSeal™ laryngeal mask airway (PLMA)
Outcome: The percentage increase in PIP from neutral to flexion | 1 | {"evidence_spans": [{"end": 10669, "start": 10533, "text": " [2.4] cm H2O, P = 0.001), [Table 2]. The percentage increase in PIP from neutral to flexion was significantly more with I-Gel\u2122 compared"}], "id": "12475", "pmcid": "5827475", "prompt_id": "12475", "split_group_id": "5827475", "votes": {"1": 2}} |
Background and Aims:
Head and neck movements alter the shape of the pharynx, resulting in changes in the oropharyngeal leaking pressures and ventilation with supragottic airway devices. We compared the effect of the different head-and-neck positions on the oropharyngeal leak pressures and ventilation with the I-Gel™ a... | Intervention: ProSeal™ laryngeal mask airway (PLMA)
Comparator: I-Gel™
Outcome: expired tidal volume inflexion | 1 | {"evidence_spans": [{"end": 10891, "start": 10788, "text": ".1% and 7.8%, respectively [Table 3].\r\nPLMA had significantly higher expired tidal volume inflexion com"}, {"end": 11041, "start": 10788, "text": ".1% and 7.8%, respectively [Table 3].\r\nPLMA had significantly higher expired tidal volume inflexion compared ... |
Background and Aims:
Head and neck movements alter the shape of the pharynx, resulting in changes in the oropharyngeal leaking pressures and ventilation with supragottic airway devices. We compared the effect of the different head-and-neck positions on the oropharyngeal leak pressures and ventilation with the I-Gel™ a... | Intervention: I-Gel™
Comparator: ProSeal™ laryngeal mask airway (PLMA)
Outcome: percentage decrease in expired tidal volume during flexion | 1 | {"evidence_spans": [{"end": 11040, "start": 10891, "text": "pared to I-Gel\u2122 (P = 0.0017) [Table 2]. Significantly greater percentage decrease in expired tidal volume was seen with I-Gel\u2122 compared to PLMA (38.6"}], "id": "12477", "pmcid": "5827475", "prompt_id": "12477", "split_group_id": "5827475", "votes": {... |
Background and Aims:
Head and neck movements alter the shape of the pharynx, resulting in changes in the oropharyngeal leaking pressures and ventilation with supragottic airway devices. We compared the effect of the different head-and-neck positions on the oropharyngeal leak pressures and ventilation with the I-Gel™ a... | Intervention: I-Gel™
Comparator: ProSeal™ laryngeal mask airway (PLMA)
Outcome: ventilation scores in all the three positions. | 0 | {"evidence_spans": [{"end": 11271, "start": 11042, "text": "vs. 23.6%) during flexion (P = 0.001).\r\nThere was worsening of ventilation score median (range) with both PLMA 1 (0\u20133) and I-Gel\u2122 1 (0\u20133) inflexion of the head-and-neck. However, the ventilation scores were comparable between the"}, {"end": 11... |
Background
Pre-workout supplements (PWS) have increased in popularity among athletic populations for their purported ergogenic benefits. Most PWS contain a “proprietary blend” of several ingredients, such as caffeine, beta-alanine, and nitrate in undisclosed dosages. Currently, little research exists on the safety and... | Intervention: Pre-workout supplements (PWS) (caffeine, beta-alanine, and nitrate in undisclosed dosages)
Comparator: remain unsupplemented (CRL)
Outcome: absolute monocytes, MCH, creatinine, eGFR , and total cholesterol | 0 | {"evidence_spans": [{"end": 2234, "start": 1974, "text": "t females. Although there were statistically significant (p\u2009<\u20090.05) group by time interactions for absolute monocytes, MCH, creatinine, eGFR, and total cholesterol, all of the results remained well within accepted physiological ranges and were not clin... |
Purpose
This study aimed to assess the effects of a psychological intervention programme on the mental stress, coping style and cortisol and IL-2 levels of patients undergoing percutaneous coronary intervention (PCI).
Methods
A total of sixty cardiovascular patients scheduled for PCI with clear anxiety and depress... | Intervention: cognitive therapy, relaxation therapy and emotional support
Comparator: control
Outcome: SCL90 | -1 | {"evidence_spans": [{"end": 18059, "start": 17967, "text": "g style and immune function\r\nIndependent sample t-tests were used to evaluate the effects of"}, {"end": 18627, "start": 18590, "text": "ng from \u00b10.52 to \u00b11.56 (Table 5).\r\n10"}], "id": "12480", "pmcid": "5777641", "prompt_id": "12480", "split_grou... |
Purpose
This study aimed to assess the effects of a psychological intervention programme on the mental stress, coping style and cortisol and IL-2 levels of patients undergoing percutaneous coronary intervention (PCI).
Methods
A total of sixty cardiovascular patients scheduled for PCI with clear anxiety and depress... | Intervention: cognitive therapy, relaxation therapy and emotional support
Comparator: control
Outcome: MCMQ | 1 | {"evidence_spans": [{"end": 18263, "start": 17916, "text": "ical intervention programme on mental stress, coping style and immune function\r\nIndependent sample t-tests were used to evaluate the effects of the intervention on mental stress, coping style and immune function (Table 4). At the post-test period, compared t... |
Purpose
This study aimed to assess the effects of a psychological intervention programme on the mental stress, coping style and cortisol and IL-2 levels of patients undergoing percutaneous coronary intervention (PCI).
Methods
A total of sixty cardiovascular patients scheduled for PCI with clear anxiety and depress... | Intervention: cognitive therapy, relaxation therapy and emotional support
Comparator: control
Outcome: IL-2 (ng/ml) | 1 | {"evidence_spans": [{"end": 985, "start": 798, "text": "sults\r\nCompared with the controls, patients in the intervention group had a better mental state and coping style (confrontation), higher levels of IL-2 and lower levels of cortisol (all P"}, {"end": 19255, "start": 19215, "text": "\r\n8.47\u00b12.56\r\n0.02\r\n\... |
Purpose
This study aimed to assess the effects of a psychological intervention programme on the mental stress, coping style and cortisol and IL-2 levels of patients undergoing percutaneous coronary intervention (PCI).
Methods
A total of sixty cardiovascular patients scheduled for PCI with clear anxiety and depress... | Intervention: cognitive therapy, relaxation therapy and emotional support
Comparator: control
Outcome: Cortisol | -1 | {"evidence_spans": [{"end": 985, "start": 798, "text": "sults\r\nCompared with the controls, patients in the intervention group had a better mental state and coping style (confrontation), higher levels of IL-2 and lower levels of cortisol (all P"}, {"end": 19303, "start": 19256, "text": "7\u00b12.44\r\n16.03\u00b13.88\... |
Purpose:
Several devices are available to take care of difficult airway, but C-MAC D-Blade has scant evidence of its use in nasotracheal intubation in a difficult airway scenario.
Aims and Objectives:
We compared the C-MAC D-Blade videolaryngoscope™, and the standard Macintosh laryngoscope for nasal intubation in ... | Intervention: C-MAC D-Blade videolaryngoscope™
Comparator: standard Macintosh laryngoscope
Outcome: The mean time taken to intubate | -1 | {"evidence_spans": [{"end": 11859, "start": 11667, "text": "eight, and EGRI scores [Table 2]. The mean time taken to intubate with Macintosh laryngoscope was 50.34 \u00b1 26.76 s whereas with C-MAC D-Blade time taken was 39.56 \u00b1 15.65 s in Group C (P < 0.05"}, {"end": 11871, "start": 11667, "text": "eight, and EGR... |
Purpose:
Several devices are available to take care of difficult airway, but C-MAC D-Blade has scant evidence of its use in nasotracheal intubation in a difficult airway scenario.
Aims and Objectives:
We compared the C-MAC D-Blade videolaryngoscope™, and the standard Macintosh laryngoscope for nasal intubation in ... | Intervention: C-MAC D-Blade videolaryngoscope™
Comparator: standard Macintosh laryngoscope
Outcome: The percentage of Cormack–Lehane Grade 1 | 1 | {"evidence_spans": [{"end": 12357, "start": 12151, "text": "tubation between Group M and Group C\r\nThe percentage of Cormack\u2013Lehane Grade 1 was much higher in the C-Mac D-Blade group as compared to Macintosh group [Table 3]. Eighty-six percent (43/50) patients had CL"}, {"end": 12642, "start": 12151, "text": "tub... |
Purpose:
Several devices are available to take care of difficult airway, but C-MAC D-Blade has scant evidence of its use in nasotracheal intubation in a difficult airway scenario.
Aims and Objectives:
We compared the C-MAC D-Blade videolaryngoscope™, and the standard Macintosh laryngoscope for nasal intubation in ... | Intervention: C-MAC D-Blade videolaryngoscope™
Comparator: standard Macintosh laryngoscope
Outcome: number of anesthetists, which considered intubations as easy | 1 | {"evidence_spans": [{"end": 1558, "start": 1459, "text": " rate and ease of intubation were found to be more in C-MAC D-Blade group than in Macintosh group ("}, {"end": 13954, "start": 13812, "text": "e of forceps to guide the tube [Table 3].\r\nThe intubating anesthetists considered 47/50 (94%) intubations as easy in ... |
Background
Online health forums are widely used, but the quality of advice differs as much as the knowledge backgrounds of the audience members who receive the advice. It is important to understand how people judge the information given online. In line with the communication accommodation theory (CAT), online forums r... | Intervention: high amounts of medical technical jargon (MTJ)
Comparator: low amounts of medical technical jargon (MTJ)
Outcome: Competence | 1 | {"evidence_spans": [{"end": 29375, "start": 29031, "text": "ignated audience in terms of credibility of information.\r\n\r\nTrustworthiness of Experts\r\nBoth main effects showed significance: MTJ affected all the 3 subscales of the METI; Expertise F1,96=37.54, P<.001, \u03b7p2=.28, Integrity, F1,96=10.77, P=.001, \u03... |
Background
Online health forums are widely used, but the quality of advice differs as much as the knowledge backgrounds of the audience members who receive the advice. It is important to understand how people judge the information given online. In line with the communication accommodation theory (CAT), online forums r... | Intervention: high amounts of medical technical jargon (MTJ)
Comparator: low amounts of medical technical jargon (MTJ)
Outcome: Integrity and Benevolence ratings | -1 | {"evidence_spans": [{"end": 2420, "start": 2064, "text": "Moreover, participants rated experts who used high amounts of MTJ to have higher competence (F1,96=37.54, P<.001, \u03b7p2=.28], lower integrity (F1,96=10.77, P=.001, \u03b7p2=.101), and lower benevolence (F1,96=9.75, P=.002, \u03b7p2=.092), as well as to have l... |
Background
Online health forums are widely used, but the quality of advice differs as much as the knowledge backgrounds of the audience members who receive the advice. It is important to understand how people judge the information given online. In line with the communication accommodation theory (CAT), online forums r... | Intervention: high amounts of medical technical jargon (MTJ)
Comparator: low amounts of medical technical jargon (MTJ)
Outcome: accommodation to the audience | -1 | {"evidence_spans": [{"end": 2420, "start": 2064, "text": "Moreover, participants rated experts who used high amounts of MTJ to have higher competence (F1,96=37.54, P<.001, \u03b7p2=.28], lower integrity (F1,96=10.77, P=.001, \u03b7p2=.101), and lower benevolence (F1,96=9.75, P=.002, \u03b7p2=.092), as well as to have l... |
Background
Online health forums are widely used, but the quality of advice differs as much as the knowledge backgrounds of the audience members who receive the advice. It is important to understand how people judge the information given online. In line with the communication accommodation theory (CAT), online forums r... | Intervention: high amounts of medical technical jargon (MTJ)
Comparator: low amounts of medical technical jargon (MTJ)
Outcome: Credibility of Information | 0 | {"evidence_spans": [{"end": 28384, "start": 28261, "text": "TJ condition\u2014were used for further analysis.\r\n\r\nCredibility of Information\r\nThere were no main effects of MTJ (F1,96=0.07, "}], "id": "12496", "pmcid": "5801514", "prompt_id": "12496", "split_group_id": "5801514", "votes": {"0": 2}} |
Postprandial glucose control remains challenging for patients with type 1 diabetes (T1D). A simplified meal bolus approach with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS) has been tested; yet, the impact of categorization errors with this strategy is unknown. The objective was to compare, in a ra... | Intervention: adequately categorized breakfast with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS)
Comparator: overestimated breakfast with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS)
Outcome: percentage of time below 4.0 mmol/L | 0 | {"evidence_spans": [{"end": 7223, "start": 7008, "text": "centage of time below 4.0\u2009mmol/L (Table\u00a03). For both meals, percentage of time <4.0\u2009mmol/L did not differ between the adequate estimation and overestimation (0 [0\u20130] vs. 0 [0\u20130]% for both meals, p\u2009=\u20090.47 and p\u2009=\u20090.3"}... |
Postprandial glucose control remains challenging for patients with type 1 diabetes (T1D). A simplified meal bolus approach with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS) has been tested; yet, the impact of categorization errors with this strategy is unknown. The objective was to compare, in a ra... | Intervention: adequately categorized breakfast with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS)
Comparator: overestimated breakfast with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS)
Outcome: time in target range (4.0 to 10.0 mmol/L), peak glucose, and time to peak glucose | 0 | {"evidence_spans": [{"end": 8187, "start": 7952, "text": ". 44 [6\u201390]; p\u2009=\u20090.14) in all interventions. No significant difference was observed in any of the other secondary outcomes including\u00a0time in target range (4.0 to 10.0\u2009mmol/L), peak glucose, and\u00a0time to peak glucose between\u00a0over... |
Postprandial glucose control remains challenging for patients with type 1 diabetes (T1D). A simplified meal bolus approach with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS) has been tested; yet, the impact of categorization errors with this strategy is unknown. The objective was to compare, in a ra... | Intervention: adequately categorized breakfast with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS)
Comparator: overestimated breakfast with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS)
Outcome: meal insulin boluses | 1 | {"evidence_spans": [{"end": 1126, "start": 882, "text": "Despite higher meal insulin boluses with overestimation for both meals (9.2 [8.2\u20139.6] vs. 8.1 [7.3\u20139.1] U and 8.4 [7.2\u201310.4] vs. 4.8 [3.7\u20135.6] U; p\u2009<\u20090.05), mean glycemia, percentage of time in target range and glucagon infusion did ... |
Postprandial glucose control remains challenging for patients with type 1 diabetes (T1D). A simplified meal bolus approach with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS) has been tested; yet, the impact of categorization errors with this strategy is unknown. The objective was to compare, in a ra... | Intervention: adequately categorized breakfast with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS)
Comparator: overestimated breakfast with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS)
Outcome: the subsequent basal insulin infusion over 4-h | 0 | {"evidence_spans": [{"end": 12008, "start": 11728, "text": "1\u201339.3]\r\n35.6 [27.0\u201345.2]\r\n23.1 [12.6\u201340.1]\r\n18.1 [12.6\u201332.7]\r\n30.9 [17.1\u201336.1]\r\n12.0 [8.5\u201329.0]\r\nGlucagon delivery, mg\r\n0 [0\u20134.1]\r\n0 [0\u201311.1]\r\n1.8 [0\u20134.7]\r\n0 [0\u20131.4]\r\n0 [0\u20130.8]\r\n0 ... |
ABSTRACT
Background:
The aim of this study was to assess the early postoperative pulmonary function and arterial blood gases in patients who have undergone open versus laparoscopic nephrectomy.
Materials and Methods:
Forty patients were randomly assigned to undergo laparoscopic (LN, n=20) or open nephrectomy (ON,... | Intervention: laparoscopic nephrectomy (LN)
Comparator: open nephrectomy (ON)
Outcome: decrease of FEV1, FVC, FEF25 and FEF25–75 after the operation | -1 | {"evidence_spans": [{"end": 8756, "start": 8403, "text": "ative first day mean pulmonary function test results are listed in Table-2. In both groups, a decrease in all spirometric variables was detected on the postoperative day 1. A decrease of 39.7%, 37.4%, 27.7%, 51.8% in Group ON and 29.9%, 32.5%, 23.2%, 44.5% in Gr... |
ABSTRACT
Background:
The aim of this study was to assess the early postoperative pulmonary function and arterial blood gases in patients who have undergone open versus laparoscopic nephrectomy.
Materials and Methods:
Forty patients were randomly assigned to undergo laparoscopic (LN, n=20) or open nephrectomy (ON,... | Intervention: laparoscopic nephrectomy (LN)
Comparator: open nephrectomy (ON)
Outcome: PEF and FIV1 | 0 | {"evidence_spans": [{"end": 1295, "start": 1215, "text": "ively). There were no significant differences in FEF50, PEF and FIV1 between the"}, {"end": 8868, "start": 8759, "text": "tive values. The difference was significantly lower in Group LN (p<0.05). PEF and FIV1 showed the same tenden"}], "id": "12502", "pmcid": "4... |
ABSTRACT
Background:
The aim of this study was to assess the early postoperative pulmonary function and arterial blood gases in patients who have undergone open versus laparoscopic nephrectomy.
Materials and Methods:
Forty patients were randomly assigned to undergo laparoscopic (LN, n=20) or open nephrectomy (ON,... | Intervention: laparoscopic nephrectomy (LN)
Comparator: open nephrectomy (ON)
Outcome: Blood gas data (PaCO2, PaO2, SaO2, pH) | 0 | {"evidence_spans": [{"end": 10407, "start": 10250, "text": "y volume at 25% to 75%; FIV1 = forced expiratory volume in 1 second; PEF = peak expiratory flow\r\n*= p<0.05 in comparison with laparoscopic group\r\n\u2020= p<0.05 i"}, {"end": 10406, "start": 10290, "text": "piratory volume in 1 second; PEF = peak expiratory... |
ABSTRACT
Background:
The aim of this study was to assess the early postoperative pulmonary function and arterial blood gases in patients who have undergone open versus laparoscopic nephrectomy.
Materials and Methods:
Forty patients were randomly assigned to undergo laparoscopic (LN, n=20) or open nephrectomy (ON,... | Intervention: laparoscopic nephrectomy (LN)
Comparator: open nephrectomy (ON)
Outcome: VAS = Visual analogue scale | 0 | {"evidence_spans": [{"end": 11746, "start": 11634, "text": " 1st day\r\n\r\n94.17 (1.91)\u2020\r\n93.27 (3.59)\u2020\r\n0.343\r\n\r\npH\r\n\r\n\r\nPreoperative\r\n\r\n7.42 (0.03)\r\n7.43 (0.02)\r\n0.290\r\n\r\nPo"}, {"end": 11747, "start": 11634, "text": " 1st day\r\n\r\n94.17 (1.91)\u2020\r\n93.27 (3.59)\u2020\r\n0.34... |
Background
Despite some preliminary evidence, it is still largely unknown whether osteopathic manipulative treatment improves preterm clinical outcomes.
Materials and Methods
The present multi-center randomized single blind parallel group clinical trial enrolled newborns who met the criteria for gestational age be... | Intervention: osteopathic manipulative treatment
Comparator: usual prenatal care
Outcome: The average hospitalization | -1 | {"evidence_spans": [{"end": 16122, "start": 15995, "text": " p value from Fisher exact test.\r\nThe study group received a median of 2 OMT sessions (range 1\u201317) and the time to the first OM"}], "id": "12505", "pmcid": "4431716", "prompt_id": "12505", "split_group_id": "4431716", "votes": {"-1": 2}} |
Background
Despite some preliminary evidence, it is still largely unknown whether osteopathic manipulative treatment improves preterm clinical outcomes.
Materials and Methods
The present multi-center randomized single blind parallel group clinical trial enrolled newborns who met the criteria for gestational age be... | Intervention: osteopathic manipulative treatment
Comparator: usual prenatal care
Outcome: The mean cost per newborn | -1 | {"evidence_spans": [{"end": 1257, "start": 1081, "text": "rmore, there were significant reductions with treatment as compared to usual care in cost (difference between study and control group: 1,586.01\u20ac; 95% CI 1,087.18 to 6,277.28; p"}, {"end": 17207, "start": 17003, "text": ".400; 3.690\r\n0.6\r\n\r\nGestational... |
Background
Despite some preliminary evidence, it is still largely unknown whether osteopathic manipulative treatment improves preterm clinical outcomes.
Materials and Methods
The present multi-center randomized single blind parallel group clinical trial enrolled newborns who met the criteria for gestational age be... | Intervention: osteopathic manipulative treatment
Comparator: usual prenatal care
Outcome: A drop-out from the study | 0 | {"evidence_spans": [{"end": 19583, "start": 19403, "text": "sured in days per gestational age (GA) measured in weeks. Groups are: control (red) and OMT (cyan). A linear quadratic effect of LOS on GA is showed in both groups but the use of O"}, {"end": 19584, "start": 19404, "text": "ured in days per gestational age (GA... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.